Endocrinology, Vol 136, 3983-3992, Copyright © 1995 by Endocrine Society

ARTICLES

Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines

I Martinez-Lacaci, M Saceda, GD Plowman, GR Johnson, N Normanno, DS Salomon and RB Dickson
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, D.C. 20007, USA.

The actions of 17 beta-estradiol (E2) and protein kinase C (PKC) appear to converge in the regulation of expression of certain growth modulatory genes, such as the growth factor amphiregulin (AR). AR is known to modulate cell growth by binding to the epidermal growth factor receptor. In the current report we established the mechanisms of the PKC-activating phorbol ester tumor promoter, 12-O-tetradecanoylphorbol- 13-acetate (TPA) and the steroid hormone E2 on the induction of AR expression in human breast carcinoma cell lines. TPA (100 nM) and E2 (1 nM) induce AR messenger RNA (mRNA) expression by 6- to 8-fold and 3- to 6-fold, respectively, in a time- and dose-dependent manner. In addition, immunoreactive AR protein is induced by both TPA and E2 by 6- to 8-fold and 2- to 4-fold, respectively. The PKC-modulating drugs, bryostatin and H-7, and antiestrogens (ICI 164,384 and 4- hydroxytamoxifen) interfere with AR induction by TPA and estrogen, respectively. The effects of TPA and E2 on the induction of AR mRNA were both closely associated with enhanced transcription of the AR gene. However, TPA had an additional effect at the posttranscriptional level by stabilizing the AR mRNA. The protein synthesis inhibitor, cycloheximide, prevented AR induction by TPA, suggesting that a component of the TPA induction of AR is indirect and dependent upon protein synthesis. Conversely, the E2 induction of AR transcription was found to be a direct response, independent of protein synthesis. The results presented herein thus demonstrate that TPA and E2 are able to stimulate AR gene transcription by two separate mechanisms.

This article has been cited by other articles:

				X. Wang, S. Masri, S. Phung, and S. Chen The Role of Amphiregulin in Exemestane-Resistant Breast Cancer Cells: Evidence of an Autocrine Loop Cancer Res., April 1, 2008; 68(7): 2259 - 2265. [Abstract] [Full Text] [PDF]

				A. Naderi, A. E. Teschendorff, J. Beigel, M. Cariati, I. O. Ellis, J. D. Brenton, and C. Caldas BEX2 Is Overexpressed in a Subset of Primary Breast Cancers and Mediates Nerve Growth Factor/Nuclear Factor-{kappa}B Inhibition of Apoptosis in Breast Cancer Cell Lines Cancer Res., July 15, 2007; 67(14): 6725 - 6736. [Abstract] [Full Text] [PDF]

				S. Lee, D. Medina, A. Tsimelzon, S. K. Mohsin, S. Mao, Y. Wu, and D. C. Allred Alterations of Gene Expression in the Development of Early Hyperplastic Precursors of Breast Cancer Am. J. Pathol., July 1, 2007; 171(1): 252 - 262. [Abstract] [Full Text] [PDF]

				J.-I. Huh, T. H. Qiu, G. V. R. Chandramouli, R. Charles, M. Wiench, G. L. Hager, R. Catena, A. Calvo, T. M. LaVallee, P.-Y. Desprez, et al. 2-Methoxyestradiol Induces Mammary Gland Differentiation through Amphiregulin-Epithelial Growth Factor Receptor-Mediated Signaling: Molecular Distinctions from the Mammary Gland of Pregnant Mice Endocrinology, March 1, 2007; 148(3): 1266 - 1277. [Abstract] [Full Text] [PDF]

				D. M. E. Harvell, J. K. Richer, D. C. Allred, C. A. Sartorius, and K. B. Horwitz Estradiol Regulates Different Genes in Human Breast Tumor Xenografts Compared with the Identical Cells in Culture Endocrinology, February 1, 2006; 147(2): 700 - 713. [Abstract] [Full Text] [PDF]

				R. van Gijn, X. Zuidema, A. Bult, and J. H. Beijnen Protein kinase C as a target for new anti-cancer agents Journal of Oncology Pharmacy Practice, December 1, 1999; 5(4): 166 - 178. [Abstract] [PDF]

				M. Silvy, P.-M. Martin, N. Chajry, and Y. Berthois Differential Dose-Dependent Effects of Epidermal Growth Factor on Gene Expression in A431 Cells: Evidence for a Signal Transduction Pathway That Can Bypass Raf-1 Activation Endocrinology, May 1, 1998; 139(5): 2382 - 2391. [Abstract] [Full Text] [PDF]

				T. L. Bale and D. M. Dorsa Cloning, Novel Promoter Sequence, and Estrogen Regulation of a Rat Oxytocin Receptor Gene Endocrinology, March 1, 1997; 138(3): 1151 - 1158. [Abstract] [Full Text] [PDF]

				S. A. Thompson, A. Harris, D. Hoang, M. Ferrer, and G. R. Johnson COOH-terminal Extended Recombinant Amphiregulin with Bioactivity Comparable with Naturally Derived Growth Factor J. Biol. Chem., July 26, 1996; 271(30): 17927 - 17931. [Abstract] [Full Text] [PDF]

				D. A. Zajchowski, K. Kauser, D. Zhu, L. Webster, S. Aberle, F. A. White III, H.-L. Liu, R. Humm, J. MacRobbie, P. Ponte, et al. Identification of Selective Estrogen Receptor Modulators by Their Gene Expression Fingerprints J. Biol. Chem., May 19, 2000; 275(21): 15885 - 15894. [Abstract] [Full Text] [PDF]